Titlebook: Management of Multiple Drug-Resistant Infections; Stephen H. Gillespie Book 2004 Springer Science+Business Media New York 2004 HIV.Malaria

友好

medium

myriad

Management of Urinary Tract Infections Caused by Multiresistant Organisms that many novel antibiotics (e.g., β-lactams and early fluoroquinolones) were being produced, resulting in many phase II and III clinical trials because UTIs, especially complicated infections, proved a good test bed for therapeutic efficacy of these compounds. There were also many protocols design

乳汁

BLAND

注射器

辩论

The Management of Multiple Drug-Resistant TuberculosisB remains the leading cause of death worldwide. Between 1998 and 2030, there are expected to be 225 million new cases of TB and 79 million deaths attributable to the disease .. It is inevitable that the number of drug-resistant cases will also increase. This has serious implications for TB control,